{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:07:51Z","timestamp":1791432471388,"version":"4.3.3"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02851-1","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:21:24Z","timestamp":1776237684000},"page":"1743-1758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid function and ultrasound surveillance in childhood cancer survivors (CCS): a position paper of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-8958","authenticated-orcid":false,"given":"Gerdi","family":"Tuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Di Mase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Vigone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Improda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Klain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Licenziati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ortolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Capalbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Di Frenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cavarzere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Penta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Munarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Felicia","family":"Faienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisabeth","family":"Street","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarolina","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cassio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000513805","volume":"54","author":"CA Lebbink","year":"2021","unstructured":"Lebbink CA, Waguespack SG, van Santen HM (2021) Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management. Front Horm Res 54:140\u2013153","journal-title":"Front Horm Res"},{"key":"2851_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2265.2005.02210.x","volume":"62","author":"HM van Santen","year":"2005","unstructured":"van Santen HM, Thonissen NM, de Kraker J et al (2005) Changes in thyroid hormone state in children receiving chemotherapy. Clin Endocrinol (Oxf) 62:250\u2013257","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2851_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1677\/jme.0.0080243","volume":"8","author":"C Massart","year":"1992","unstructured":"Massart C, Le Tellier C, Lucas C et al (1992) Effects of cisplatin on human thyrocytes in monolayer or follicle culture. J Mol Endocrinol 8:243\u2013248","journal-title":"J Mol Endocrinol"},{"key":"2851_CR4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/jnci\/djr373","volume":"103","author":"OP Hamnvik","year":"2011","unstructured":"Hamnvik OP, Larsen PR, Marqusee E (2011) Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst 103:1572\u20131587","journal-title":"J Natl Cancer Inst"},{"key":"2851_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1089\/thy.2013.0241","volume":"23","author":"F Torino","year":"2013","unstructured":"Torino F, Barnabei A, Paragliola R et al (2013) Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid 23:1345\u20131366","journal-title":"Thyroid"},{"key":"2851_CR6","doi-asserted-by":"crossref","unstructured":"Cattoni A, Molinari S, Gaiero A et al (2022) Thyroid Disorders Following Hematopoietic Stem Cell Transplantation in Childhood: Impact of Conditioning Regimen on Thyroid Dysfunction, Volume Changes, and Occurrence of Nodules. Transplant Cell Ther 28:506.e1-506.e12","DOI":"10.1016\/j.jtct.2022.05.040"},{"key":"2851_CR7","doi-asserted-by":"publisher","first-page":"103958","DOI":"10.1016\/j.critrevonc.2023.103958","volume":"184","author":"S van der Leij","year":"2023","unstructured":"van der Leij S, Lebbink CA, Lentjes EG et al (2023) Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer: A systematic review. Crit Rev Oncol Hematol 184:103958","journal-title":"Crit Rev Oncol Hematol"},{"key":"2851_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.semcancer.2020.12.008","volume":"79","author":"A Basolo","year":"2022","unstructured":"Basolo A, Matrone A, Elisei R et al (2022) Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism. Semin Cancer Biol 79:197\u2013202","journal-title":"Semin Cancer Biol"},{"key":"2851_CR9","first-page":"1255","volume":"25","author":"F Pani","year":"2015","unstructured":"Pani F, Atzori F, Baghino G et al (2015) Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib. Is Thyroid Autoimmun Involved? Thyroid 25:1255\u20131261","journal-title":"Is Thyroid Autoimmun Involved? Thyroid"},{"key":"2851_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","volume":"36","author":"Y Tomer","year":"2007","unstructured":"Tomer Y, Blackard JT, Akeno N (2007) Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 36:1051\u20131066","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2851_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cncr.23251","volume":"112","author":"A Hauschild","year":"2008","unstructured":"Hauschild A, Gogas H, Tarhini A et al (2008) Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer 112:982\u2013994","journal-title":"Cancer"},{"key":"2851_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355","journal-title":"Science"},{"key":"2851_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41574-021-00484-3","volume":"17","author":"JJ Wright","year":"2021","unstructured":"Wright JJ, Powers AC, Johnson DB (2021) Endocrine toxicities of immune checkpoint inhibitors. Nat Rev Endocrinol 17:389\u2013399","journal-title":"Nat Rev Endocrinol"},{"key":"2851_CR14","doi-asserted-by":"publisher","first-page":"101660","DOI":"10.1016\/j.beem.2022.101660","volume":"36","author":"S Iwama","year":"2022","unstructured":"Iwama S, Kobayashi T, Yasuda Y et al (2022) Immune checkpoint inhibitor-related thyroid dysfunction. Best Pract Res Clin Endocrinol Metab 36:101660","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2851_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","volume":"18","author":"HA Tawbi","year":"2017","unstructured":"Tawbi HA, Burgess M, Bolejack V et al (2017) Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 18:1493\u20131501","journal-title":"Lancet Oncol"},{"key":"2851_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1470-2045(19)30693-X","volume":"21","author":"B Geoerger","year":"2020","unstructured":"Geoerger B, Zwaan CM, Marshall LV et al (2020) Atezolizumab for children and young adults with previously treated solid tumors, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1\u20132 study. Lancet Oncol 21:134\u2013144","journal-title":"Lancet Oncol"},{"key":"2851_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1470-2045(19)30671-0","volume":"21","author":"B Geoerger","year":"2020","unstructured":"Geoerger B, Kang HJ, Yalon-Oren M et al (2020) Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumor or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1\u20132 trial. Lancet Oncol 21:121\u2013133","journal-title":"Lancet Oncol"},{"key":"2851_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1470-2045(20)30023-1","volume":"21","author":"KL Davis","year":"2020","unstructured":"Davis KL, Fox E, Merchant MS et al (2020) Nivolumab in children and young adults with relapsed or refractory solid tumors or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1\u20132 trial. Lancet Oncol 21:541\u2013550","journal-title":"Lancet Oncol"},{"key":"2851_CR19","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/neuonc\/noad031","volume":"25","author":"IJ Dunkel","year":"2023","unstructured":"Dunkel IJ, Doz F, Foreman NK et al (2023) Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics. Neuro Oncol 25:1530\u20131545","journal-title":"Neuro Oncol"},{"key":"2851_CR20","doi-asserted-by":"publisher","first-page":"eabb7495","DOI":"10.1126\/scitranslmed.abb7495","volume":"13","author":"Y Yasuda","year":"2021","unstructured":"Yasuda Y, Iwama S, Sugiyama D et al (2021) CD4(+) T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in thyroglobulin-immunized mice. Sci Transl Med 13:eabb7495","journal-title":"Sci Transl Med"},{"key":"2851_CR21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA et al (2006) Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572\u20131582","journal-title":"N Engl J Med"},{"key":"2851_CR22","first-page":"65","volume":"69","author":"R Nandagopal","year":"2008","unstructured":"Nandagopal R, Laverdi\u00e8re C, Mulrooney D et al (2008) Endocrine late effects of childhood cancer therapy: a report from the Children\u2019s Oncology Group. Horm Res 69:65\u201374","journal-title":"Horm Res"},{"key":"2851_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"JD Rizzo","year":"2006","unstructured":"Rizzo JD, Wingard JR, Tichelli A et al (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl 12:138\u2013151","journal-title":"Biol Blood Marrow Transpl"},{"key":"2851_CR24","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-22-0689","volume":"187","author":"ES Husebye","year":"2022","unstructured":"Husebye ES, Castinetti F, Criseno S et al (2022) Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. Eur J Endocrinol 187:G1\u2013G21","journal-title":"Eur J Endocrinol"},{"key":"2851_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/eje.1.02255","volume":"155","author":"P Vejbjerg","year":"2006","unstructured":"Vejbjerg P, Knudsen N, Perrild H et al (2006) The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur J Endocrinol 155:547\u2013552","journal-title":"Eur J Endocrinol"},{"key":"2851_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/BF03343925","volume":"24","author":"T Rago","year":"2001","unstructured":"Rago T, Chiovato L, Grasso L et al (2001) Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest 24:763\u2013769","journal-title":"J Endocrinol Invest"},{"key":"2851_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40618-014-0083-8","volume":"37","author":"M Rotondi","year":"2014","unstructured":"Rotondi M, Coperchini F, Magri F et al (2014) Serum-negative autoimmune thyroiditis: what\u2019s in a name? J Endocrinol Invest 37:589\u2013591","journal-title":"J Endocrinol Invest"},{"key":"2851_CR28","first-page":"4472","volume":"84","author":"SR Rose","year":"1999","unstructured":"Rose SR, Lustig RH, Pitukcheewanont P et al (1999) Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84:4472\u20134479","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000495040","volume":"91","author":"SG Waguespack","year":"2019","unstructured":"Waguespack SG (2019) Thyroid Sequelae of Pediatric Cancer Therapy. Horm Res Paediatr 91:104\u2013117","journal-title":"Horm Res Paediatr"},{"key":"2851_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrendo.2016.45","volume":"12","author":"SR Rose","year":"2016","unstructured":"Rose SR, Horne VE, Howell J et al (2016) Late endocrine effects of childhood cancer. Nat Rev Endocrinol 12:319\u2013336","journal-title":"Nat Rev Endocrinol"},{"key":"2851_CR31","unstructured":"Surveillance E, Program ER, National Cancer Institute (2024). SEER Cancer Statistics Review 1975\u20132018. Posted April 15, 2021. Accessed June 27. https:\/\/seer.cancer.gov\/csr\/1975_2018\/"},{"key":"2851_CR32","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","volume":"390","author":"N Bhakta","year":"2017","unstructured":"Bhakta N, Liu Q, Ness KK et al (2017) The cumulative burden of surviving childhood cancer. Lancet 390:2569\u20132582","journal-title":"Lancet"},{"key":"2851_CR33","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2016.66.6545","volume":"34","author":"S Mostoufi-Moab","year":"2016","unstructured":"Mostoufi-Moab S, Seidel K, Leisenring WM et al (2016) Endocrine abnormalities in aging survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 34:3240\u20133247","journal-title":"J Clin Oncol"},{"key":"2851_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1667\/RR14888.1","volume":"190","author":"PD Inskip","year":"2018","unstructured":"Inskip PD, Veiga LHS, Brenner AV, Shet al (2018) Hypothyroidism after Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res 190:117\u2013132","journal-title":"Radiat Res"},{"key":"2851_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ijrobp.2019.02.009","volume":"104","author":"PD Inskip","year":"2019","unstructured":"Inskip PD, Veiga LHS, Brenner AV et al (2019) Hyperthyroidism after radiation therapy for childhood cancer: A report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys 104:415\u2013424","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2851_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2011.03.002","volume":"99","author":"MJ Boomsma","year":"2011","unstructured":"Boomsma MJ, Bijl HP, Langendijk JA (2011) Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol 99:1\u20135","journal-title":"Radiother Oncol"},{"key":"2851_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ijrobp.2021.02.001","volume":"119","author":"MT Milano","year":"2024","unstructured":"Milano MT, Vargo JA, Yorke ED et al (2024) Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 119:482\u2013493","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2851_CR38","first-page":"83","volume":"33","author":"JCH Chow","year":"2022","unstructured":"Chow JCH, Cheung KM, Cheung GTC et al (2022) Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review. Clin Transl Radiat Oncol 33:83\u201392","journal-title":"Clin Transl Radiat Oncol"},{"key":"2851_CR39","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1002\/cncr.26186","volume":"117","author":"IR Vogelius","year":"2011","unstructured":"Vogelius IR, Bentzen SM, Maraldo MV et al (2011) Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer 117:5250\u20135260","journal-title":"Cancer"},{"key":"2851_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.7150\/jca.48587","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou L, Chen J, Tao C-J et al (2021) Research progress of radiation-induced hypothyroidism in head and neck cancer. J Cancer 12:451\u2013459","journal-title":"J Cancer"},{"key":"2851_CR41","unstructured":"Children\u2019s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers: version 6.0 (2023) (October http:\/\/www.survivorshipguidelines.org"},{"key":"2851_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2023.16875","volume":"330","author":"S Bhatia","year":"2023","unstructured":"Bhatia S, Tonorezos ES, Landier W (2023) Clinical Care for People Who Survive Childhood Cancer: A Review. JAMA 330:1175\u20131186","journal-title":"JAMA"},{"key":"2851_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00259-014-2967-4","volume":"42","author":"SC Clement","year":"2015","unstructured":"Clement SC, van Rijn RR, van Eck-Smit BLF et al (2015) Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma. Eur J Nucl Med Mol Imaging 42:706\u2013715","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2851_CR44","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/cncr.10447","volume":"94","author":"HM van Santen","year":"2002","unstructured":"van Santen HM, de Kraker J, van Eck BLF et al (2002) High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I-meta-iodobenzylguanidine treatment in children with neuroblastoma. Cancer 94:2081\u20132089","journal-title":"Cancer"},{"key":"2851_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/pbc.22767","volume":"56","author":"A Quach","year":"2011","unstructured":"Quach A, Ji L, Mishra V et al (2011) Thyroid and hepatic function after high-dose 131I-metaiodobenzylguanidine (131I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer 56:191\u2013201","journal-title":"Pediatr Blood Cancer"},{"key":"2851_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12149-022-01743-7","volume":"36","author":"SC Clement","year":"2022","unstructured":"Clement SC, Tytgat GAM, van Trotsenburg ASP et al (2022) Thyroid function after diagnostic 123I-metaiodobenzylguanidine in children with neuroblastic tumors. Ann Nucl Med 36:579\u2013585","journal-title":"Ann Nucl Med"},{"key":"2851_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000491388","volume":"7","author":"L Persani","year":"2018","unstructured":"Persani L, Brabant G, Dattani M et al (2018) European thyroid association (ETA) guidelines on the diagnosis and management of Central hypothyroidism. Eur Thyroid J 7:225\u2013237","journal-title":"Eur Thyroid J"},{"key":"2851_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/JPEM.2004.17.1.55","volume":"17","author":"SR Rose","year":"2004","unstructured":"Rose SR, Schreiber RE, Kearney NS et al (2004) Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17:55\u201366","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2851_CR49","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1515\/JPEM.2011.407","volume":"24","author":"F Baronio","year":"2011","unstructured":"Baronio F, Battisti L, Radetti G (2011) Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia. J Pediatr Endocrinol Metab 24:903\u2013906","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2851_CR50","first-page":"1477","volume":"12","author":"L Amy","year":"2022","unstructured":"Amy L, Wanaguru DJ, Tait et al (2022) Central hypothyroidism after chemotherapy in childhood cancer survivors: a single centre series. Acta Oncol 12:1477\u20131480","journal-title":"Acta Oncol"},{"key":"2851_CR51","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1210\/jc.2019-00834","volume":"104","author":"L van Iersel","year":"2019","unstructured":"van Iersel L, Li Z, Srivastava DK et al (2019) Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab 104:6101\u20136115","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12887-023-03900-x","volume":"23","author":"HY Jin","year":"2023","unstructured":"Jin HY, Lee JA, Park M et al (2023) Characteristics and clinical course of thyroid abnormalities arisen in long term survivors of childhood cancer. BMC Pediatr 23:124","journal-title":"BMC Pediatr"},{"key":"2851_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.seizure.2016.01.010","volume":"35","author":"Y-X Zhang","year":"2016","unstructured":"Zhang Y-X, Shen C-H, Lai Q-L et al (2016) Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: a meta-analysis. Seizure 35:72\u201379","journal-title":"Seizure"},{"key":"2851_CR54","first-page":"18","volume":"2018","author":"PD Oddie","year":"2018","unstructured":"Oddie PD, Albert BB, Hofman PL et al (2018) Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor. Endocrinol Diabetes Metab Case Rep 2018:18\u20130059","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2851_CR55","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/en.2009-1404","volume":"151","author":"MC Zatelli","year":"2010","unstructured":"Zatelli MC, Gentilin E, Daffara F et al (2010) Therapeutic concentrations of mitotane (o,p\u2019-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology 151:2453\u20132461","journal-title":"Endocrinology"},{"key":"2851_CR56","first-page":"526","volume":"124","author":"AP van Seters","year":"1991","unstructured":"van Seters AP, Moolenaar AJ (1991) Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol 124:526\u2013553","journal-title":"Acta Endocrinol"},{"key":"2851_CR57","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1210\/jcem-28-3-386","volume":"28","author":"JS Marshall","year":"1968","unstructured":"Marshall JS, Tompkins LS (1968) Effect of o, p_- DDD and similar compounds on thyroxinee binding globulin. J Clin Endocrinol Metab 28:386\u2013439","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR58","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3390\/cancers12092615","volume":"12","author":"V Basile","year":"2020","unstructured":"Basile V, Puglisi S, Calabrese A et al (2020) Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer. Cancers (Basel) 12:2615","journal-title":"Cancers (Basel)"},{"key":"2851_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cam4.4854","volume":"12","author":"A Hiraoka","year":"2023","unstructured":"Hiraoka A, Kumada T, Tada T et al (2023) Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib. Cancer Med 12:325\u2013334","journal-title":"Cancer Med"},{"key":"2851_CR60","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1210\/clinem\/dgad260","volume":"108","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Jiao X, Lai X (2023) Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction. J Clin Endocrinol Metab 108:2916\u20132923","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR61","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.pcl.2020.08.002","volume":"67","author":"HM Van Santen","year":"2020","unstructured":"Van Santen HM, Chemaitilly W, Meacham LR et al (2020) Endocrine Health in Childhood Cancer Survivors. Pediatr Clin N Am 67:1171\u20131186","journal-title":"Pediatr Clin N Am"},{"key":"2851_CR62","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1210\/jc.2019-00539","volume":"104","author":"L van Iersel","year":"2019","unstructured":"van Iersel L, Xu J, Potter BS et al (2019) Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors. J Clin Endocrinol Metab 104:4998\u20135007","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR63","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1210\/jc.2018-01175","volume":"103","author":"CA Sklar","year":"2018","unstructured":"Sklar CA, Antal Z, Chemaitilly W et al (2018) Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society Clinical practice guideline. J Clin Endocrinol Metab 103:2761\u20132784","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR64","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/endrev\/bnab040","volume":"43","author":"L van Iersel","year":"2022","unstructured":"van Iersel L, Mulder RL, Denzer C et al (2022) Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. Endocr Rev 43:794\u2013823","journal-title":"Endocr Rev"},{"key":"2851_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000493943","volume":"91","author":"W Chemaitilly","year":"2019","unstructured":"Chemaitilly W, Sklar CA (2019) Childhood Cancer Treatments and Associated Endocrine Late Effects: A Concise Guide for the Pediatric Endocrinologist. Horm Res Paediatr 91:74\u201382","journal-title":"Horm Res Paediatr"},{"key":"2851_CR66","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1542\/peds.2010-3849","volume":"129","author":"I Filges","year":"2012","unstructured":"Filges I, Bischof-Renner A, R\u00f6thlisberger B et al (2012) Panhypopituitarism presenting as life-threatening heart failure caused by an inherited microdeletion in 1q25 including LHX4. Pediatrics 129:e529\u2013e534","journal-title":"Pediatrics"},{"key":"2851_CR67","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/children9111617","volume":"9","author":"F Claude","year":"2022","unstructured":"Claude F, Ubertini G, Szinnai G (2022) Endocrine Disorders in Children with Brain Tumors: At Diagnosis, after Surgery, Radiotherapy and Chemotherapy. Child Basel 9:1617","journal-title":"Child Basel"},{"key":"2851_CR68","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1200\/JCO.2016.67.5025","volume":"34","author":"SC Clement","year":"2016","unstructured":"Clement SC, Schouten-van Meeteren AY, Boot AM et al (2016) Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study. J Clin Oncol 34:4362\u20134370","journal-title":"J Clin Oncol"},{"key":"2851_CR69","doi-asserted-by":"publisher","first-page":"e2156","DOI":"10.1210\/clinem\/dgab893","volume":"107","author":"LG Gonz\u00e1lez Brice\u00f1o","year":"2022","unstructured":"Gonz\u00e1lez Brice\u00f1o LG, Kariyawasam D, Samara-Boustani D et al (2022) High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort. J Clin Endocrinol Metab 107:e2156\u2013e2166","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR70","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrendo.2017.47","volume":"13","author":"P Beck-Peccoz","year":"2017","unstructured":"Beck-Peccoz P, Rodari G, Giavoli C et al (2017) Central hypothyroidism \u2013 a neglected thyroid disorder. Nat Rev Endocrinol 13:588\u2013598","journal-title":"Nat Rev Endocrinol"},{"key":"2851_CR71","first-page":"25","volume":"14","author":"S Benvenga","year":"2018","unstructured":"Benvenga S, Klose M, Vita R et al (2018) Less known aspects of central hypothyroidism. J Clin Transl Endocrinol 14:25\u201333","journal-title":"J Clin Transl Endocrinol"},{"key":"2851_CR72","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11154-024-09876-y","volume":"25","author":"J Abucham","year":"2024","unstructured":"Abucham J, Martins M (2024) Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist? Rev Endocr Metab Disord 25:609\u2013618","journal-title":"Rev Endocr Metab Disord"},{"key":"2851_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2265.2000.01071.x","volume":"53","author":"ES Portes","year":"2000","unstructured":"Portes ES, Oliveira JH, MacCagnan P et al (2000) Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf) 53:183\u2013189","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2851_CR74","doi-asserted-by":"publisher","unstructured":"Leung AM, Brent GA (2016) Growth Hormone Deficiency: The Influence of Thyroid Hormone on Growth Hormone Secretion and Action. In: Cohen L (ed) Growth Hormone Deficiency. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-28038-7_4","DOI":"10.1007\/978-3-319-28038-7_4"},{"key":"2851_CR75","doi-asserted-by":"publisher","first-page":"e29942","DOI":"10.1002\/pbc.29942","volume":"69","author":"JJG Welch","year":"2022","unstructured":"Welch JJG, Ames B, Cohen LE et al (2022) Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study. Pediatr Blood Cancer 69:e29942","journal-title":"Pediatr Blood Cancer"},{"key":"2851_CR76","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N et al (2016) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:3888\u20133921","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17446651.2019.1620599","volume":"14","author":"JC Howell","year":"2019","unstructured":"Howell JC, Rose SR (2019) Pituitary disease in pediatric brain tumor survivors. Expert Rev Endocrinol Metab 14:283\u2013291","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2851_CR78","first-page":"e220382","volume":"12","author":"I van Maa","year":"2022","unstructured":"van Maa I, Bakker B, van Santen HM et al (2022) Hormone replacement in survivors of childhood cancer and brain tumors: safety and controversies. Endocr Connect 12:e220382","journal-title":"Endocr Connect"},{"key":"2851_CR79","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1200\/JCO.2017.76.3268","volume":"36","author":"W Chemaitilly","year":"2018","unstructured":"Chemaitilly W, Cohen LE, Mostoufi-Moab S et al (2018) Endocrine Late Effects in Childhood Cancer Survivors. J Clin Oncol 36:2153\u20132159","journal-title":"J Clin Oncol"},{"key":"2851_CR80","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2008.21.1953","volume":"27","author":"L Diller","year":"2009","unstructured":"Diller L, Chow EJ, Gurney JG et al (2009) Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 27:2339\u20132355","journal-title":"J Clin Oncol"},{"key":"2851_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4274\/jcrpe.1326","volume":"6","author":"AA \u00c7a\u011flar","year":"2014","unstructured":"\u00c7a\u011flar AA, O\u011fuz A, P\u0131narl\u0131 FG et al (2014) Thyroid abnormalities in survivors of childhood cancer. J Clin Res Pediatr Endocrinol 6:144\u20131451","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2851_CR82","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0360-3016(96)00480-4","volume":"36","author":"K Nishiyama","year":"1996","unstructured":"Nishiyama K, Kozuka T, Higashihara T et al (1996) Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 36:1221\u20131224","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2851_CR83","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1667\/RR1953.1","volume":"174","author":"E Ron","year":"2010","unstructured":"Ron E, Brenner A (2010) Non-malignant thyroid diseases after a wide range of radiation exposures. Radiat Res 174:877\u2013888","journal-title":"Radiat Res"},{"key":"2851_CR84","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJM199108293250902","volume":"325","author":"SL Hancock","year":"1991","unstructured":"Hancock SL, Cox RS, McDougall IR (1991) Thyroid diseases after treatment of Hodgkin\u2019s disease. N Engl J Med 325:599\u2013605","journal-title":"N Engl J Med"},{"key":"2851_CR85","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/pbc.22082","volume":"53","author":"EJ Chow","year":"2009","unstructured":"Chow EJ, Friedman DL, Stovall M et al (2009) Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 53:432\u2013437","journal-title":"Pediatr Blood Cancer"},{"key":"2851_CR86","first-page":"3227","volume":"85","author":"C Sklar","year":"2000","unstructured":"Sklar C, Whitton J, Mertens A et al (2000) Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227\u20133232","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000067269","volume":"109","author":"A Ill\u00e9s","year":"2003","unstructured":"Ill\u00e9s A, B\u00edr\u00f3 E, Milt\u00e9nyi Z et al (2003) Hypothyroidism and thyroiditis after therapy for Hodgkin\u2019s disease. Acta Haematol 109:11\u201317","journal-title":"Acta Haematol"},{"key":"2851_CR88","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/0284186X.2018.1535187","volume":"58","author":"CT Clausen","year":"2019","unstructured":"Clausen CT, Hasle H, Holmqvist AS et al (2019) Hyperthyroidism as a late effect in childhood cancer survivors - an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Acta Oncol 58:227\u2013231","journal-title":"Acta Oncol"},{"key":"2851_CR89","doi-asserted-by":"publisher","first-page":"G17","DOI":"10.2741\/A714","volume":"6","author":"C Sklar","year":"2001","unstructured":"Sklar C, Boulad F, Small T et al (2001) Endocrine complications of pediatric stem cell transplantation. Front Biosci 6:G17\u201322","journal-title":"Front Biosci"},{"key":"2851_CR90","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1089\/thy.2012.0618","volume":"23","author":"A Sinha","year":"2013","unstructured":"Sinha A, Abinun M, Gennery AR et al (2013) Graves\u2019 immune reconstitution inflammatory syndrome in childhood. Thyroid 23:1010\u20131114","journal-title":"Thyroid"},{"key":"2851_CR91","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/pbc.22767","volume":"56","author":"A Quach","year":"2011","unstructured":"Quach A, Ji L, Mishra V, Sznewajs A et al (2011) Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer 56:191\u2013201","journal-title":"Pediatr Blood Cancer"},{"key":"2851_CR92","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ando.2018.07.003","volume":"79","author":"D Drui","year":"2018","unstructured":"Drui D, Illouz F, Do Cao C et al (2018) Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors. Ann Endocrinol (Paris) 79:569\u2013573","journal-title":"Ann Endocrinol (Paris)"},{"key":"2851_CR93","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/thy.2018.0116","volume":"28","author":"PC Iyer","year":"2018","unstructured":"Iyer PC, Cabanillas ME, Waguespack SG et al (2018) Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid 28:1243\u20131251","journal-title":"Thyroid"},{"key":"2851_CR94","unstructured":"Children\u2019s Oncology Group (2018) Long Term Follow-up Guidelines for Survivors od CHildhood, Adolescent and Young Adult Cancer, Version 4.0"},{"key":"2851_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2017.11.005","volume":"63","author":"SC Clement","year":"2018","unstructured":"Clement SC, Kremer LCM, Verburg FA et al (2018) Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat Rev 63:28\u201339","journal-title":"Cancer Treat Rev"},{"key":"2851_CR96","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/thy.2014.0460","volume":"25","author":"GL Francis","year":"2015","unstructured":"Francis GL, Waguespack SG, Bauer AJ et al (2015) American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 25:716\u2013759","journal-title":"Thyroid"},{"key":"2851_CR97","doi-asserted-by":"publisher","first-page":"e220146","DOI":"10.1530\/ETJ-22-0146","volume":"11","author":"CA Lebbink","year":"2022","unstructured":"Lebbink CA, Links TP, Czarniecka A et al (2022) 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 11:e220146","journal-title":"Eur Thyroid J"},{"key":"2851_CR98","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00259-014-2967-4","volume":"42","author":"SC Clement","year":"2015","unstructured":"Clement SC, van Rijn RR, van Eck-Smit BL et al (2015) Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma. Eur J Nucl Med Mol Imaging 42:706\u2013715","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2851_CR99","first-page":"767","volume":"8","author":"G Sapuppo","year":"2021","unstructured":"Sapuppo G, Tavarelli M, Cannata E et al (2021) Risk of Benign and Malignant Thyroid Disorders in Subjects Treated for Paediatric\/Adolescent Neoplasia: Role of Morphological and Functional Screening. Child (Basel) 8:767","journal-title":"Child (Basel)"},{"key":"2851_CR100","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000531241","volume":"97","author":"JA Baran","year":"2024","unstructured":"Baran JA, Halada S, Bauer AJ et al (2024) Thyroid Ultrasound Screening in Childhood Cancer Survivors following Radiotherapy. Horm Res Paediatr 97:243\u2013253","journal-title":"Horm Res Paediatr"},{"key":"2851_CR101","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejca.2015.12.006","volume":"55","author":"E Brignardello","year":"2016","unstructured":"Brignardello E, Felicetti F, Castiglione A et al (2016) Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer. Eur J Cancer 55:74\u201380","journal-title":"Eur J Cancer"},{"key":"2851_CR102","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12022-006-0001-5","volume":"17","author":"YE Nikiforov","year":"2006","unstructured":"Nikiforov YE (2006) Radiation-induced thyroid cancer: what we have learned from chernobyl. Endocr Pathol 17:307\u2013317","journal-title":"Endocr Pathol"},{"issue":"Suppl 2","key":"2851_CR103","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1038\/onc.2009.349","volume":"27","author":"D Williams","year":"2008","unstructured":"Williams D (2008) Radiation carcinogenesis: lessons from Chernobyl. Oncogene 27(Suppl 2):S9\u201318","journal-title":"Oncogene"},{"key":"2851_CR104","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrendo.2016.11","volume":"12","author":"C Romei","year":"2016","unstructured":"Romei C, Ciampi R, Elisei R (2016) A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol 12:192\u2013202","journal-title":"Nat Rev Endocrinol"},{"key":"2851_CR105","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.radonc.2018.10.022","volume":"132","author":"N Journy","year":"2019","unstructured":"Journy N, Indelicato DJ, Withrow DR et al (2019) Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol 132:155\u2013161","journal-title":"Radiother Oncol"},{"key":"2851_CR106","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/EJE-20-0153","volume":"183","author":"SC Clement","year":"2020","unstructured":"Clement SC, Lebbink CA, Klein Hesselink MS et al (2020) Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study. Eur J Endocrinol 183:169\u2013180","journal-title":"Eur J Endocrinol"},{"key":"2851_CR107","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1210\/jc.2015-1690","volume":"100","author":"F de Vathaire","year":"2015","unstructured":"de Vathaire F, Haddy N, Allodji RS et al (2015) Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer. J Clin Endocrinol Metab 100:4282\u20134290","journal-title":"J Clin Endocrinol Metab"},{"key":"2851_CR108","doi-asserted-by":"crossref","unstructured":"Li Z, Franklin J, Zelcer S et al (2014) Ultrasound surveillance for thyroid malignancies in survivors of childhood cancer following radiotherapy: a single institutional experience, vol 24. Thyroid, pp 1796\u20131805","DOI":"10.1089\/thy.2014.0132"},{"key":"2851_CR109","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00431-016-2692-z","volume":"175","author":"WL Ho","year":"2016","unstructured":"Ho WL, Zacharin MR (2016) Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure. Eur J Pediatr 175:677\u2013683","journal-title":"Eur J Pediatr"},{"key":"2851_CR110","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MPH.0000000000000473","volume":"38","author":"C Agrawal","year":"2016","unstructured":"Agrawal C, Guthrie L, Sturm MS et al (2016) Comparison of Thyroid Nodule Prevalence by Ultrasound in Childhood Cancer Survivors With and Without Thyroid Radiation Exposure. J Pediatr Hematol Oncol 38:43\u201348","journal-title":"J Pediatr Hematol Oncol"},{"key":"2851_CR111","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yapd.2017.03.007","volume":"64","author":"CM Chan","year":"2017","unstructured":"Chan CM, Prager J, Travers S (2017) Pediatric Thyroid Cancer. Adv Pediatr 64:171\u2013190","journal-title":"Adv Pediatr"},{"key":"2851_CR112","doi-asserted-by":"publisher","first-page":"E911","DOI":"10.3390\/ijms18050911","volume":"18","author":"E Albi","year":"2017","unstructured":"Albi E, Cataldi S, Lazzarini A et al (2017) Radiation and thyroid cancer. Int J Mol Sci 18:E911","journal-title":"Int J Mol Sci"},{"key":"2851_CR113","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","volume":"365","author":"AJ Sigurdson","year":"2005","unstructured":"Sigurdson AJ, Ronckers CM, Mertens AC et al (2005) Primary thyroid cancer after a first tumor in childhood (the childhood cancer survivor study): a nested case-control study. Lancet Lond Engl 365:2014\u20132023","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"2851_CR114","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3857\/roj.2018.00290","volume":"36","author":"CB Dracham","year":"2018","unstructured":"Dracham CB, Shankar A, Madan R (2018) Radiation induced secondary malignancies: a review article. Radiat Oncol 36(2):85\u201394. 10.3857\/ roj.2018.00290","journal-title":"Radiat Oncol"},{"key":"2851_CR115","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","volume":"113","author":"JD Rizzo","year":"2009","unstructured":"Rizzo JD, Curtis RE, Soci\u00e9 G et al (2009) Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113:1175\u20131183","journal-title":"Blood"},{"key":"2851_CR116","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2006.08.9276","volume":"25","author":"A Cohen","year":"2007","unstructured":"Cohen A, Rovelli A, Merlo DF et al (2007) Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT late effects working party study. J Clin Oncol 25:2449\u20132454","journal-title":"J Clin Oncol"},{"key":"2851_CR117","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11764-016-0588-6","volume":"11","author":"ES Tonorezos","year":"2017","unstructured":"Tonorezos ES, Barnea D, Moskowitz CS et al (2017) Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation. J Cancer Surviv 11:302\u2013308","journal-title":"J Cancer Surviv"},{"key":"2851_CR118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","volume":"21","author":"LH Veiga","year":"2012","unstructured":"Veiga LH, Bhatti P, Ronckers CM et al (2012) Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 21:92\u2013101","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2851_CR119","doi-asserted-by":"publisher","first-page":"798974","DOI":"10.3389\/fped.2021.798974","volume":"9","author":"N Zubarovskaya","year":"2022","unstructured":"Zubarovskaya N, Bauer D, Ronceray L et al (2022) To lighten the burden of cure: Thyroid disease in long-term survivors after TBI conditioning for paediatric ALL. Front Pediatr 9:798974","journal-title":"Front Pediatr"},{"key":"2851_CR120","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/cen.14665","volume":"96","author":"V Duarte","year":"2022","unstructured":"Duarte V, Maciel J, Cavaco D et al (2022) Predictive factors for thyroid complications after radiation therapy-data from a cohort of cancer patients closely followed since they were irradiated. Clin Endocrinol (Oxf) 96:728\u2013733","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2851_CR121","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1182\/blood-2008-08-173005","volume":"113","author":"JE Sanders","year":"2009","unstructured":"Sanders JE, Hoffmeister PA, Woolfrey AE et al (2009) Thyroid function following hematopoietic cell transplantation in children: 30 years\u2019 experience. Blood 113:306\u2013308","journal-title":"Blood"},{"key":"2851_CR122","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-12-0073","volume":"167","author":"M Vivanco","year":"2012","unstructured":"Vivanco M, Dalle JH, Alberti C et al (2012) Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood. Eur J Endocrinol 167:225\u2013233","journal-title":"Eur J Endocrinol"},{"key":"2851_CR123","doi-asserted-by":"publisher","first-page":"1064146","DOI":"10.3389\/fendo.2022.1064146","volume":"13","author":"A Cattoni","year":"2022","unstructured":"Cattoni A, Molinari S, Riva B et al (2022) Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up. Front Endocrinol (Lausanne) 13:1064146","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2851_CR124","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/leu.2014.203","volume":"29","author":"AS Nelson","year":"2015","unstructured":"Nelson AS, Ashton LJ, Vajdic CM et al (2015) Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia 29:441\u2013447","journal-title":"Leukemia"},{"key":"2851_CR125","doi-asserted-by":"publisher","first-page":"R299","DOI":"10.1530\/ERC-16-0113","volume":"23","author":"M Wijnen","year":"2016","unstructured":"Wijnen M, van den Heuvel-Eibrink MM, Medici M et al (2016) Risk factors for subsequent endocrine-related cancer in childhood cancer survivors. Endocr Relat Cancer 23:R299\u2013321","journal-title":"Endocr Relat Cancer"},{"key":"2851_CR126","doi-asserted-by":"publisher","first-page":"914942","DOI":"10.3389\/fped.2022.914942","volume":"10","author":"C Martucci","year":"2022","unstructured":"Martucci C, Crocoli A, De Pasquale MD et al (2022) Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors. Front Pediatr 10:914942","journal-title":"Front Pediatr"},{"key":"2851_CR127","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/jimaging10080189","volume":"10","author":"C Gambale","year":"2024","unstructured":"Gambale C, Rocha JV, Prete A et al (2024) Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules. J Imaging 10:189","journal-title":"J Imaging"},{"key":"2851_CR128","first-page":"320","volume":"112","author":"W Dorffel","year":"2015","unstructured":"Dorffel W, Riepenhausenl M, Luders H et al (2015) Secondary malignancies following treatment for Hodgkin\u2019s lymphoma in childhood and adolescence. Dtsch Arztebl Int 112:320\u2013327","journal-title":"Dtsch Arztebl Int"},{"key":"2851_CR129","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13014-015-0521-6","volume":"10","author":"I Finke","year":"2015","unstructured":"Finke I, Scholz-Kreisel P, Hennewig U et al (2015) Radiotherapy and subsequent thyroid cancer in German childhood cancer survivors: a nested case-control study. Radiat Oncol 10:219","journal-title":"Radiat Oncol"},{"key":"2851_CR130","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10555-020-09864-z","volume":"39","author":"U Paetow","year":"2020","unstructured":"Paetow U, Bader P, Chemaitilly W (2020) A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation. Cancer Metastasis Rev 39:69\u201378","journal-title":"Cancer Metastasis Rev"},{"key":"2851_CR131","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cen.14746","volume":"97","author":"G Atlas","year":"2022","unstructured":"Atlas G, Farrell S, Zacharin M (2022) Secondary thyroid carcinoma in survivors of childhood cancer: A need to revise current screening recommendations. Clin Endocrinol (Oxf) 97:137\u2013139","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2851_CR132","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ped.14179","volume":"62","author":"Y Furui","year":"2020","unstructured":"Furui Y, Morita D, Okura E et al (2020) Thyroid tumor surveillance using ultrasound in childhood cancer survivors. Pediatr Int 62:562\u2013568","journal-title":"Pediatr Int"},{"key":"2851_CR133","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3324\/haematol.2015.140053","volume":"101","author":"C Oudin","year":"2016","unstructured":"Oudin C, Auquier P, Bertrand Y et al (2016) Late thyroid complications in survivors of childhood acute leukemia. an L.E.A. study. Haematologica 101:747\u2013756","journal-title":"Haematologica"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02851-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:35Z","timestamp":1787040155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":133,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02851-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have nothing to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}